News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
281 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17849)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (122)
2 (3)
3 (17)
4 (317)
5 (398)
6 (369)
7 (315)
8 (144)
9 (1)
10 (24)
11 (168)
12 (366)
13 (237)
14 (253)
15 (114)
16 (13)
17 (22)
18 (269)
19 (262)
20 (224)
21 (281)
22 (109)
23 (5)
24 (7)
25 (43)
26 (133)
27 (210)
28 (19)
29 (25)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
Business
Patterson Companies Second-Quarter Fiscal 2020 Conference Call Scheduled for Thursday, December 5, 2019
The company’s earnings release will be issued that morning before the market opens.
November 21, 2019
·
1 min read
Drug Development
Inotrem Announces Enrollment of First Patient in its Phase IIb ASTONISH Trial for Nangibotide in the Treatment of Septic Shock
Inotrem S.A. announced it has initiated its Phase IIb ASTONISH trial to evaluate nangibotide in the treatment of septic shock and has enrolled the first patient in the trial.
November 21, 2019
·
3 min read
Pharmaceutical Drug Development Services Market Procurement Intelligence Report | Pharmaceutical Drug Development Services Suppliers, Pharmaceutical Drug Development Services Price Trends and Procurement Insights Now Available from SpendEdge
SpendEdge, a global procurement market intelligence firm, has announced the release of its Global Pharmaceutical Drug Development Services Market - Procurement Intelligence Report.
November 21, 2019
·
5 min read
FUNET builds 400G-ready network on ADVA FSP 3000 open line system
ROADM technology and ALM fiber monitoring solution ensure reliable, high-capacity connectivity across Finland
November 21, 2019
·
4 min read
Business
Company Profile for Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. is a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients.
November 21, 2019
·
1 min read
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
Novel clinical-stage asset shows activity against drug-resistant fungal infections that pose a significant health threat and have limited treatment options
November 21, 2019
·
9 min read
Business
Xeris Pharmaceuticals Provides a Business Update During Recent Investor Conference
MAA submitted to EMA of liquid stable glucagon for severe hypoglycemia
November 21, 2019
·
9 min read
Business
STAT’s First-ever Biomedical Innovation Award Awarded to Dr. Charles Sawyers, Chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center
The award was announced on Nov. 21 at the inaugural STAT Summit, and celebrates one academic researcher who has had an enormous impact on the field of medicine.
November 21, 2019
·
2 min read
Deals
Amgen Completes Acquisition Of Otezla® (apremilast)
Amgen (NASDAQ:AMGN) today announced the successful completion of its acquisition of worldwide rights to Otezla® (apremilast), the only oral, non-biologic treatment for moderate-to-severe plaque psoriasis and psoriatic arthritis.
November 21, 2019
·
17 min read
Abacus Health Products Expands its CBDMEDIC Offering to Additional Major Retail Pharmacy Chain
Abacus Health Products, Inc. (CSE: ABCS, OTCQX:ABAHF) (“Abacus” or the “Company”) today announced that it has received a purchase order from an additional major national pharmacy chain in the United States, which will be offering products from its CBDMEDIC product line
November 21, 2019
·
4 min read
Previous
10 of 29
Next